TY - JOUR
T1 - A national survey of medical students' beliefs and knowledge in screening for prostate cancer
AU - Marcella, Stephen
AU - Delnevo, Cristine D.
AU - Coughlin, Steven S.
N1 - Funding Information:
Acknowledgments: This study was funded via a cooperative agreement between the Centers for Disease Control and Prevention and the Association of Teachers of Preventive Medicine under award TS-313-15/15. We also would like to acknowledge the following schools that participated in the study: Brown Medical School, University at Buffalo SUNY School of Medicine & Biomedical Sciences, University of Cincinnati College of Medicine, Weill Medical College of Cornell University, University of Florida College of Medicine, Medical College of Georgia School of Medicine, Howard University College of Medicine, University of Illinois College of Medicine, University of Louisville School of Medicine, Mercer University School of Medicine, University of Minnesota Medical School, Morehouse School of Medicine, University of North Dakota School of Medicine and Health Sciences, University of South Florida College of Medicine, University of Texas Southwestern Medical Center, Stanford University School of Medicine, Temple University School of Medicine, University of Vermont College of Medicine, Wayne State University School of Medicine, and Yale University School of Medicine.
PY - 2007/1
Y1 - 2007/1
N2 - BACKGROUND: Today's medical students are being educated at a time when there are no evidence-based guidelines for prostate cancer screening. OBJECTIVE: To examine medical students' knowledge and beliefs concerning prostate cancer screening and specific determinants for their beliefs. DESIGN, SETTING, AND PARTICIPANTS: One thousand six hundred and forty four students were sampled at 20 medical schools using a web-based, cross-sectional survey. MAIN OUTCOME MEASURES: Basic knowledge and beliefs about prostate cancer testing, epidemiology, and therapy were ascertained. RESULTS: Four of 8 knowledge items were answered incorrectly by 50% or more of students. Seven of 8 students believe that early diagnosis from screening can improve survival from prostate cancer. Second- and third-year students were more likely than fourth-year students to believe that the digital rectal exam (DRE) and the prostate-specific antigen test were accurate, adjusted odds ratio (AOR) 1.8; 95% confidence interval (CI), 1.2 to 2.7 and 1.7; 1.3 to 2.2 for second and third years, respectively, for the DRE. Black and Hispanic students were no more likely than white students to agree that early screening diagnosis improves survival, but blacks were more likely to agree with screening black or Hispanic men (AOR 7.8; 95% CI, 5.3 to 11.4 and 3.2; 2.2 to 4.7, respectively). More knowledgeable students were less likely to believe in the benefit of early detection and the accuracy of the prostate-specific antigen (AOR 0.3; 95%CI, 0.2 to 0.5). CONCLUSIONS: Medical students generally are very optimistic about the benefits of screening for prostate cancer. Increased knowledge about prostate cancer is associated with a more conservative view of screening. Other predictors are independent of this knowledge.
AB - BACKGROUND: Today's medical students are being educated at a time when there are no evidence-based guidelines for prostate cancer screening. OBJECTIVE: To examine medical students' knowledge and beliefs concerning prostate cancer screening and specific determinants for their beliefs. DESIGN, SETTING, AND PARTICIPANTS: One thousand six hundred and forty four students were sampled at 20 medical schools using a web-based, cross-sectional survey. MAIN OUTCOME MEASURES: Basic knowledge and beliefs about prostate cancer testing, epidemiology, and therapy were ascertained. RESULTS: Four of 8 knowledge items were answered incorrectly by 50% or more of students. Seven of 8 students believe that early diagnosis from screening can improve survival from prostate cancer. Second- and third-year students were more likely than fourth-year students to believe that the digital rectal exam (DRE) and the prostate-specific antigen test were accurate, adjusted odds ratio (AOR) 1.8; 95% confidence interval (CI), 1.2 to 2.7 and 1.7; 1.3 to 2.2 for second and third years, respectively, for the DRE. Black and Hispanic students were no more likely than white students to agree that early screening diagnosis improves survival, but blacks were more likely to agree with screening black or Hispanic men (AOR 7.8; 95% CI, 5.3 to 11.4 and 3.2; 2.2 to 4.7, respectively). More knowledgeable students were less likely to believe in the benefit of early detection and the accuracy of the prostate-specific antigen (AOR 0.3; 95%CI, 0.2 to 0.5). CONCLUSIONS: Medical students generally are very optimistic about the benefits of screening for prostate cancer. Increased knowledge about prostate cancer is associated with a more conservative view of screening. Other predictors are independent of this knowledge.
KW - Medical students
KW - Prostate cancer
KW - Screening
UR - http://www.scopus.com/inward/record.url?scp=34248549635&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34248549635&partnerID=8YFLogxK
U2 - 10.1007/s11606-006-0015-1
DO - 10.1007/s11606-006-0015-1
M3 - Article
C2 - 17351844
AN - SCOPUS:34248549635
VL - 22
SP - 80
EP - 85
JO - Journal of General Internal Medicine
JF - Journal of General Internal Medicine
SN - 0884-8734
IS - 1
ER -